Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPRT1 | P00492 | 1/20 | 0.53 |
| ▸ | EGFR | P00533 | 1/20 | 0.51 |
| ▸ | PTPRC | P08575 | 3/20 | 0.46 |
| ▸ | S100A4 | P26447 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 6/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7047314 | 0.90 | EGFR (0.51) | HPRT1EGFRPTPRCS100A4CA1 | |
| SCHEMBL10018096 | 0.81 | HPRT1 (0.42) | HPRT1EGFRPTPRCS100A4CA1 | |
| SCHEMBL11588993 | 0.79 | HPRT1 (0.69) | HPRT1EGFRPTPRCS100A4CA1 | |
| SCHEMBL10943739 | 0.79 | HPRT1 (0.74) | HPRT1EGFRPTPRCS100A4CA1 | |
| SCHEMBL11586212 | 0.76 | HPRT1 (0.70) | HPRT1EGFRPTPRCS100A4CA1 | |
| SCHEMBL11695991 | 0.74 | HPRT1 (0.67) | HPRT1EGFRPTPRCS100A4CA1 | |
| SCHEMBL11589459 | 0.74 | HPRT1 (0.63) | HPRT1EGFRPTPRCS100A4CA1 | |
| SCHEMBL7047553 | 0.73 | EGFR (0.44) | EGFRCA1CA2CA7CA9 | |
| SCHEMBL8525627 | 0.72 | TDP1 (0.62) | HPRT1EGFRPTPRCS100A4CA1 | |
| SCHEMBL7049233 | 0.71 | EGFR (0.38) | EGFRS100A4KDM4EMAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1300132-A2 | Agent for dyeing keratinous fibres | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-04-09 | — | — | EP | claimed |
| US-20170192352-A1 | PHOTOACID GENERATOR | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2017-07-06 | — | — | US | disclosed |
| US-20170192353-A1 | PHOTORESIST COMPOSITION, COATED SUBSTRATE INCLUDING THE PHOTORESIST COMPOSITION, AND METHOD OF FORMING ELECTRONIC DEVICE | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2017-07-06 | — | — | US | disclosed |
| US-8120019-B2 | Organic light-emitting element having tetracyano compound and display device | CANON KABUSHIKI KAISHA (JP) | 2012-02-21 | — | — | US | disclosed |
| EP-1300132-A2 | Agent for dyeing keratinous fibres | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-04-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170192353-A1 | PHOTORESIST COMPOSITION, COATED SUBSTRATE INCLUDING THE PHOTORESIST COMPOSITION, AND METHOD OF FORMING ELECTRONIC DEVICE | PPIG, PARG, EEF1G | HPRT1 298/4885EGFR 533/4885PTPRC 1344/4885 |
| US-20170192352-A1 | PHOTOACID GENERATOR | RARG, PPIG, ATP6V1G1 | HPRT1 55/4885EGFR 1733/4885PTPRC 3156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.